Non-interventional Study on the Safety and Efficacy for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2018
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Adverse reactions
- Acronyms ERADICATE
- Sponsors Astellas Pharma
- 24 Jul 2018 Status changed from active, no longer recruiting to completed.
- 07 Jun 2018 Planned End Date changed from 1 Nov 2019 to 1 Jun 2018.
- 07 Jun 2018 Planned primary completion date changed from 1 Nov 2019 to 1 Jun 2018.